1-20 of 25
Jessica Pollard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Asciminib pediatric formulation shows a tolerable safety profile in pediatric patients with chronic myeloid leukemia in chronic phase (CML-CP): Second interim analysis from the ASC4KIDS study

Free
Jessica Pollard, Hiroyuki Shimada, Shruti Kapoor, Matthias Hoch, Vishal Dhamal, Nithya Agrawal, Christine Rosko, Ana Paula Cardoso, Masakatsu Yanagimachi, Ho Joon Im, Markus Metzler, Nobuko Hijiya
Journal: Blood
Blood (2025) 146 (Supplement 1): 7312.
https://doi.org/10.1182/blood-2025-7312
Published: 2025
Journal Articles

Analysis of 3346 patients from the combined Children's Oncology Group AML studies further characterizes RAM immunophenotype AML and reveals other associated phenotypes and genetic drivers.

Free
Andrew Menssen, Jacqueline Cook, Todd Alonzo, Robert Gerbing, Maria Pardo, Fan-Chi Hsu, Loren Lott, Fangyan Dai, Amenech Ashango, Thanh Thanh Dinh, Todd Cooper, Jessica Pollard, Katherine Tarlock, Lisa Brodersen, Michael Loken, Soheil Meshinchi, Chad Hudson
Journal: Blood
Blood (2025) 146 (Supplement 1): 337.
https://doi.org/10.1182/blood-2025-337
Published: 2025
Journal Articles

NUP98::NSD1 fusion is associated with poor outcomes in Acute Myeloid Leukemia regardless of co-occurring mutations and treatment regimen

Free
Katherine Tarlock, Danielle Kirkey, Rhonda Ries, Jack H. Peplinski, Todd Alonzo, Robert Gerbing, Jim Wang, Todd Cooper, Alan Gamis, Richard Aplenc, Martina Pigazzi, Franco Locatelli, Jessica Pollard, Soheil Meshinchi
Journal: Blood
Blood (2025) 146 (Supplement 1): 1702.
https://doi.org/10.1182/blood-2025-1702
Published: 2025
Journal Articles

Etoposide can be safely removed from induction chemotherapy without impacting survival for pediatric acute myeloid leukemia – a report from the Children's oncology group study AAML1831

Free
Jenna Rossoff, Jing Chen, Todd Alonzo, Jim Wang, Richard Aplenc, Alan Gamis, Betsy Hirsch, Gordana Raca, Soheil Meshinchi, Anders Kolb, Sarah Tasian, Jessica Pollard, Matthew Kutny, Todd Cooper
Journal: Blood
Blood (2025) 146 (Supplement 1): 877.
https://doi.org/10.1182/blood-2025-877
Published: 2025
Journal Articles

Central nervous system disease status significantly impacts survival in pediatric acute myeloid leukemia: A report from Children's Oncology Group study AAML1831

Free
Zachary Graff, Todd Alonzo, Robert Gerbing, Jim Wang, Jessica Pollard, Soheil Meshinchi, Alan Gamis, Richard Aplenc, Betsy Hirsch, Gordana Raca, Todd Cooper, Matthew Kutny
Journal: Blood
Blood (2025) 146 (Supplement 1): 872.
https://doi.org/10.1182/blood-2025-872
Published: 2025
Journal Articles

Germline predisposition in pediatric malignancies: Insights from a retrospective study at Dana-Farber Cancer Institute

Free
Sabrina Testa, Akiko Shimamura, Junne Kamihara, Jaclyn Schienda, Corinne Echmalian, Cecilia Miguel, Gwen Muscato, Abigail Ward, Suneet Agarwal, Serine Avagyan, Melissa Burns, Brian Crompton, Kimberly Davies, Barbara Degar, Lisa Diller, Angela Feraco, Alyssa Kennedy, Jennifer Kesselheim, Jonathan Paolino, Andrew Place, R. Grant Rowe, Lewis Silverman, Yana Pikman, Kayla Hamilton, Jessica Pollard
Journal: Blood
Blood (2025) 146 (Supplement 1): 3213.
https://doi.org/10.1182/blood-2025-3213
Published: 2025
Journal Articles

FLT3 (CD135) expression in pediatric AML is associated with specific disease characteristics and worse outcome in the setting of sorafenib theraphy: A report from the Children's Oncology Group AAML1031 protocol.

Free
Andrew Menssen, Amenech Ashango, Todd Alonzo, Robert Gerbing, Maria Pardo, Fan-Chi Hsu, Loren Lott, Fangyan Dai, Todd Cooper, Jessica Pollard, Katherine Tarlock, Richard Aplenc, Soheil Meshinchi, Lisa Brodersen, Michael Loken, Chad Hudson
Journal: Blood
Blood (2025) 146 (Supplement 1): 5256.
https://doi.org/10.1182/blood-2025-5256
Published: 2025
Journal Articles

Epigenetic priming improves survival for pediatric Acute Myeloid Leukemia: Results from the multicenter randomized AML16 trial

Free
Tanja Gruber, Stanley Pounds, Norman Lacayo, Kenneth Heym, Meret Henry, Barbara Degar, Deborah Schiff, Faisal Razzaqi, Jamie Frediani, Samuel Milanovich, Jennifer McNeer, Huiyun Wu, Lakshmi Patibandla, Emily Xiong, Tamara Westover, Ryan Hiltenbrand, Lu Wang, Priya Kumar, Gabrielle Lapping-Carr, Kayelyn Wagner, Dennis Kuo, Jessica Pollard, Nickhill Bhakta, Seth Karol, Brandon Triplett, Jatinder Lamba, Hiroto Inaba, Ching-Hon Pui, Raul Ribeiro, Jeffrey Rubnitz, Jeffery Klco
Journal: Blood
Blood (2025) 146 (Supplement 1): 3446.
https://doi.org/10.1182/blood-2025-3446
Published: 2025
Journal Articles

Optimized treatment for pediatric patients with low-risk Acute Myeloid Leukemia: A report from the Children's oncology group study AAML1831

Free
Reena Pabari, Chana Glasser, Todd Alonzo, Jim Wang, Richard Aplenc, Alan Gamis, Betsy Hirsch, Gordana Raca, Soheil Meshinchi, Kasey Leger, Kelly Getz, Anders Kolb, Jessica Pollard, Sarah Tasian, Matthew Kutny, Todd Cooper
Journal: Blood
Blood (2025) 146 (Supplement 1): 878.
https://doi.org/10.1182/blood-2025-878
Published: 2025
Journal Articles

Post-transplant maintenance with sorafenib is safe and effective in pediatric patients with har FLT3/ITD AML: A report from the Children's oncology group protocol AAML1031

Free
Caitlin Elgarten, Todd Alonzo, Robert Gerbing, John Choi, Brian Fisher, Betsy Hirsch, Samir Kahwash, John Levine, Lisa Brodersen, Michael Loken, Susana Raimondi, Katherine Tarlock, Andrew Wood, Lillian Sung, Todd Cooper, Alan Gamis, Soheil Meshinchi, Richard Aplenc, Jessica Pollard
Journal: Blood
Blood (2025) 146 (Supplement 1): 1644.
https://doi.org/10.1182/blood-2025-1644
Published: 2025
Journal Articles

A phase I study of venetoclax in combination with multiagent cytotoxic chemotherapy for children and adolescents with relapsed or refractory acute lymphoblastic leukemia or mixed phenotype acute leukemia: Results of the dose determination cohort

Free
Melissa Burns, Yael Flamand, Jessica Pollard, Elliot Stieglitz, Loretta Li, Naomi Parikh, Sarah Cronholm, Lauren Buckley, Christine Braun, Krista Cardini, Bayla Shepley, Jonathan Paolino, Yana Pikman, Andrew Place
Journal: Blood
Blood (2025) 146 (Supplement 1): 5125.
https://doi.org/10.1182/blood-2025-5125
Published: 2025
Journal Articles

The Addition of Bortezomib to Standard Chemotherapy for Pediatric Acute Myeloid Leukemia Has Increased Toxicity without Therapeutic Benefit: A Report from the Children's Oncology Group

Free
Richard Aplenc, MD PhD, Soheil Meshinchi, MD PhD, Lillian Sung, MD PhD FRCPC, Todd A. Alonzo, PhD, Jessica Pollard, MD, Robert Gerbing, BS, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Michael R. Loken, PhD, Laura Winter, PharmD, Samir B. Kahwash, John K Choi, MD, John E Levine, MD MS, E. Anders Kolb, MD, Alan S. Gamis, MD MPH
Journal: Blood
Blood (2016) 128 (22): 899.
https://doi.org/10.1182/blood.V128.22.899.899
Published: 2016
Journal Articles

Prognostic Significance of 11q23/ MLL Fusion Partners in Children with Acute Myeloid Leukemia (AML) - Results from the Children's Oncology Group (COG) Trial AAML0531

Free
Erin M. Guest, MD, Betsy A. Hirsch, PhD, E. Anders Kolb, MD, Todd A. Alonzo, PhD, Robert Gerbing, BS, Richard Aplenc, MD PhD, Jessica Pollard, MD, Lillian Sung, MD PhD FRCPC, Soheil Meshinchi, MD PhD, Alan S. Gamis, MD MPH, Susana C. Raimondi, PhD
Journal: Blood
Blood (2016) 128 (22): 1211.
https://doi.org/10.1182/blood.V128.22.1211.1211
Published: 2016
Journal Articles

Mutational Concordance from Diagnosis and Relapse in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Free
Katherine Tarlock, MD, Todd M Cooper, DO, Todd A. Alonzo, PhD, Robert Gerbing, BS, Jessica Pollard, MD, Richard Aplenc, MD PhD, E. Anders Kolb, MD, Alan S. Gamis, MD MPH, Soheil Meshinchi, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2846.
https://doi.org/10.1182/blood.V128.22.2846.2846
Published: 2016
Journal Articles

CD33 Splicing Polymorphism Is a Strong Predictor of Therapeutic Efficacy of Gemtuzumab Ozogamicin in De Novo AML: Report from COG-AAML0531 Study

Free
Jatinder K Lamba, PhD, Lata Chauhan, PhD, Michael R. Loken, PhD, Jessica Pollard, MD, Yi-Cheng Wang, MS, Ries E Rhonda, Richard Aplenc, MD PhD, Betsy A. Hirsch, PhD, Susana C. Raimondi, PhD, Roland B. Walter, MD PhD, Irwin D. Bernstein, MD, Alan S. Gamis, MD MPH, Todd A. Alonzo, PhD, Soheil Meshinchi, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2743.
https://doi.org/10.1182/blood.V128.22.2743.2743
Published: 2016
Journal Articles

Relapse Following Initial Remission and Subsequent Outcome for Children with Relapsed Acute Myeloid Leukemia on the AAML0531 Phase III Study of Gemtuzumab Ozogamicin: A Report from the Children's Oncology Group

Free
Todd M Cooper, DO, Robert B. Gerbing, MA, Todd A. Alonzo, PhD, Jessica Pollard, MD, Lillian Sung, MD PhD FRCPC, E. Anders Kolb, MD, Richard Aplenc, MD PhD, Soheil Meshinchi, MD PhD, Alan S. Gamis, MD MPH
Journal: Blood
Blood (2016) 128 (22): 2794.
https://doi.org/10.1182/blood.V128.22.2794.2794
Published: 2016
Journal Articles

Genetic Variations in Calicheamicin Pathway Genes Are Predictors of Gemtuzumab Ozogamicin Response in AML Patients: Results from COG-AAML0531 Study

Free
Jatinder K Lamba, PhD, Lata Chauhan, PhD, Richard Aplenc, MD PhD, Maggie Skrypek, MD, Jessica Pollard, MD, Todd A. Alonzo, PhD, Y-C Wang, Irwin D. Bernstein, MD, Alan S. Gamis, MD MPH, Soheil Meshinchi, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1260.
https://doi.org/10.1182/blood.V126.23.1260.1260
Published: 2015
Journal Articles

Treatment of 11q23/ MLL + AML with Gemtuzumab Ozogamicin: Results from the Randomized Phase III Children's Oncology Group Trial AAML0531

Free
Jessica Pollard, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Lillian Sung, MD PhD, Richard Aplenc, MD PhD, Erin M. Guest, MD, Irwin D. Bernstein, MD, Michael R. Loken, PhD, Soheil Meshinchi, MD PhD, Alan S. Gamis, MD MPH
Journal: Blood
Blood (2015) 126 (23): 799.
https://doi.org/10.1182/blood.V126.23.799.799
Published: 2015
Journal Articles

Prevalence and Prognostic Significance of KIT Mutations in Pediatric Core Binding Factor AML Patients Treated with Gemtuzumab Ozogamicin: Results from the Randomized Phase III Children's Oncology Group Trial AAML0531

Free
Jessica Pollard, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Yi-Cheng Wang, MS, Jason Joaquin, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Lillian Sung, MD PhD, Richard Aplenc, MD PhD, Irwin D. Bernstein, MD, Alan S. Gamis, MD MPH, Soheil Meshinchi, MD PhD
Journal: Blood
Blood (2015) 126 (23): 800.
https://doi.org/10.1182/blood.V126.23.800.800
Published: 2015
Journal Articles

Chemosensitization and Mobilization Of AML/ALL/MDS With Plerixafor (AMD 3100), a CXCR4 Antagonist: A Phase I Study Of Plerixafor + Cytarabine and Etoposide In Pediatric Patients With Acute Leukemia and MDS

Free
Todd Michael Cooper, Sharyn D. Baker, PharmD, PhD, Jennifer Direnzo, Tanya M. Trippett, Lia Gore, MD, Aru Narendran, MD, PhD, Keith J. August, M.D., M.Sc., Michael J. Absalon, MD, PhD, Jessica Boklan, MD, Jessica Pollard, MD, Daniel Magoon, Edward Allan R. Sison, MD, Patrick Brown, MD
Journal: Blood
Blood (2013) 122 (21): 2680.
https://doi.org/10.1182/blood.V122.21.2680.2680
Published: 2013